IPO Boutique

Achilles Therapeutics Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Achilles Therapeutics Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Achilles Therapeutics Inc.ACHL -
NASDAQ
$17.00-$19.00 $18.00 $18.009.75 million ADSs3/31/2021
JP Morgan, BofA Securities, Piper Sandler
Co-Manager(s):
Chardan, Oppenheimer & Co., Kempen & Co
Health Care
Filing(s):

Filed 2021-03-01
Terms Added 2021-03-25



Achilles Therapeutics Inc. Quote & Chart - Click for current quote - ACHL

About Achilles Therapeutics Inc. (adapted from Achilles Therapeutics Inc. prospectus):
They are a clinical stage immuno-oncology biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumors.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ACHL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved